INNOVATE (NYSE:VATE) Posts Earnings Results

INNOVATE (NYSE:VATE) announced its quarterly earnings results on Thursday. The company reported ($1.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.18) by $0.89, Zacks reports. The company had revenue of $364.80 million for the quarter, compared to analyst estimates of $251.70 million.

Here are the key takeaways from INNOVATE’s conference call:

• Consolidated Q1 revenue rose 33% to $364.8 million, and adjusted EBITDA improved to $19.7 million from $7.2 million a year ago, helped by stronger infrastructure and life sciences performance.
• Infrastructure remained the growth engine, with DBM Global revenue up 35.1% to $357.9 million and adjusted EBITDA of $23 million, while adjusted backlog stayed at a robust $1.8 billion and management highlighted early progress on 2027 backlog.
• Life Sciences made regulatory and clinical progress, including CE mark approval for the TGFR Monitor and reusable sensor, successful audit completion, and multiple IDE approvals that should support upcoming clinical enrollment.
• R2 saw solid demand momentum with $1.6 million in Q1 revenue, $2.2 million in total demand, and a backlog of about 160 systems globally, though management said the business is looking to raise external capital to continue its progress.
• Spectrum continued to face pressure from softer advertising demand and network cancellations, as revenue fell to $5.3 million and adjusted EBITDA slipped to $0.7 million, even as the company pointed to regulatory and strategic opportunities ahead.

INNOVATE Stock Performance

NYSE VATE opened at $10.82 on Friday. The firm has a 50 day simple moving average of $8.29 and a 200-day simple moving average of $6.27. INNOVATE has a one year low of $3.75 and a one year high of $13.46. The firm has a market cap of $147.52 million, a price-to-earnings ratio of -2.54 and a beta of 2.27.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of INNOVATE in a research report on Wednesday, January 21st. Wall Street Zen upgraded shares of INNOVATE to a “buy” rating in a research report on Saturday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, INNOVATE has an average rating of “Sell”.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Squarepoint Ops LLC purchased a new position in INNOVATE in the third quarter worth approximately $58,000. Bank of America Corp DE lifted its stake in INNOVATE by 13.4% in the third quarter. Bank of America Corp DE now owns 18,962 shares of the company’s stock worth $93,000 after acquiring an additional 2,236 shares during the last quarter. Citadel Advisors LLC lifted its stake in INNOVATE by 60.2% in the third quarter. Citadel Advisors LLC now owns 37,694 shares of the company’s stock worth $184,000 after acquiring an additional 14,163 shares during the last quarter. Finally, Jane Street Group LLC purchased a new position in INNOVATE in the fourth quarter worth approximately $51,000. Hedge funds and other institutional investors own 34.28% of the company’s stock.

INNOVATE Company Profile

INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.